Global Propranolol Market Growth 2023-2029

Propranolol, sold under the brand name Inderal among others, is a medication of the beta blocker class. It is used to treat high blood pressure, a number of types of irregular heart rate, thyrotoxicosis, capillary hemangiomas, performance anxiety, and essential tremors. It is used to prevent migraine headaches, and to prevent further heart problems in those with angina or previous heart attacks. It can be taken by mouth or by injection into a vein.

LPI (LP Information)' newest research report, the “Propranolol Industry Forecast” looks at past sales and reviews total world Propranolol sales in 2022, providing a comprehensive analysis by region and market sector of projected Propranolol sales for 2023 through 2029. With Propranolol sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Propranolol industry.

This Insight Report provides a comprehensive analysis of the global Propranolol landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Propranolol portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Propranolol market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Propranolol and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Propranolol.

The global Propranolol market size is projected to grow from US$ 377.6 million in 2022 to US$ 471.3 million in 2029; it is expected to grow at a CAGR of 471.3 from 2023 to 2029.

Global Propranolol key players include Apotex, Teva, Atnas Pharma, AstraZeneca, Mylan, etc. Global top five manufacturers hold a share over 28%.

Europe is the largest market, with a share about 30%, followed by North America, and Asia-Pacific, both have a share about 44 percent. 
In terms of product, Oral is the largest segment, with a share over 98%. And in terms of application, the largest application is Arrhythmia, followed by Hypertension, and Others.

This report presents a comprehensive overview, market shares, and growth opportunities of Propranolol market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Oral
    Injection

Segmentation by application
    Arrhythmia
    Hypertension
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Apotex
    Teva
    Atnas Pharma
    AstraZeneca
    Mylan
    Novartis
    Sanofi
    Yabang Pharma
    Sawai Seiyaku
    ABZ-Pharma
    Towa Yakuhin
    Zydus Pharma
    Nichi-Iko Pharmaceutical
    Intas Pharma
    IFET
    Iqfarma
    Zentiva

Key Questions Addressed in this Report
What is the 10-year outlook for the global Propranolol market?
What factors are driving Propranolol market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Propranolol market opportunities vary by end market size?
How does Propranolol break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

List of Tables
    Table 1. Propranolol Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
    Table 2. Propranolol Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
    Table 3. Major Players of Oral
    Table 4. Major Players of Injection
    Table 5. Global Propranolol Sales by Type (2018-2023) & (K Units)
    Table 6. Global Propranolol Sales Market Share by Type (2018-2023)
    Table 7. Global Propranolol Revenue by Type (2018-2023) & ($ million)
    Table 8. Global Propranolol Revenue Market Share by Type (2018-2023)
    Table 9. Global Propranolol Sale Price by Type (2018-2023) & (US$/Unit)
    Table 10. Global Propranolol Sales by Application (2018-2023) & (K Units)
    Table 11. Global Propranolol Sales Market Share by Application (2018-2023)
    Table 12. Global Propranolol Revenue by Application (2018-2023)
    Table 13. Global Propranolol Revenue Market Share by Application (2018-2023)
    Table 14. Global Propranolol Sale Price by Application (2018-2023) & (US$/Unit)
    Table 15. Global Propranolol Sales by Company (2018-2023) & (K Units)
    Table 16. Global Propranolol Sales Market Share by Company (2018-2023)
    Table 17. Global Propranolol Revenue by Company (2018-2023) ($ Millions)
    Table 18. Global Propranolol Revenue Market Share by Company (2018-2023)
    Table 19. Global Propranolol Sale Price by Company (2018-2023) & (US$/Unit)
    Table 20. Key Manufacturers Propranolol Producing Area Distribution and Sales Area
    Table 21. Players Propranolol Products Offered
    Table 22. Propranolol Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Propranolol Sales by Geographic Region (2018-2023) & (K Units)
    Table 26. Global Propranolol Sales Market Share Geographic Region (2018-2023)
    Table 27. Global Propranolol Revenue by Geographic Region (2018-2023) & ($ millions)
    Table 28. Global Propranolol Revenue Market Share by Geographic Region (2018-2023)
    Table 29. Global Propranolol Sales by Country/Region (2018-2023) & (K Units)
    Table 30. Global Propranolol Sales Market Share by Country/Region (2018-2023)
    Table 31. Global Propranolol Revenue by Country/Region (2018-2023) & ($ millions)
    Table 32. Global Propranolol Revenue Market Share by Country/Region (2018-2023)
    Table 33. Americas Propranolol Sales by Country (2018-2023) & (K Units)
    Table 34. Americas Propranolol Sales Market Share by Country (2018-2023)
    Table 35. Americas Propranolol Revenue by Country (2018-2023) & ($ Millions)
    Table 36. Americas Propranolol Revenue Market Share by Country (2018-2023)
    Table 37. Americas Propranolol Sales by Type (2018-2023) & (K Units)
    Table 38. Americas Propranolol Sales by Application (2018-2023) & (K Units)
    Table 39. APAC Propranolol Sales by Region (2018-2023) & (K Units)
    Table 40. APAC Propranolol Sales Market Share by Region (2018-2023)
    Table 41. APAC Propranolol Revenue by Region (2018-2023) & ($ Millions)
    Table 42. APAC Propranolol Revenue Market Share by Region (2018-2023)
    Table 43. APAC Propranolol Sales by Type (2018-2023) & (K Units)
    Table 44. APAC Propranolol Sales by Application (2018-2023) & (K Units)
    Table 45. Europe Propranolol Sales by Country (2018-2023) & (K Units)
    Table 46. Europe Propranolol Sales Market Share by Country (2018-2023)
    Table 47. Europe Propranolol Revenue by Country (2018-2023) & ($ Millions)
    Table 48. Europe Propranolol Revenue Market Share by Country (2018-2023)
    Table 49. Europe Propranolol Sales by Type (2018-2023) & (K Units)
    Table 50. Europe Propranolol Sales by Application (2018-2023) & (K Units)
    Table 51. Middle East & Africa Propranolol Sales by Country (2018-2023) & (K Units)
    Table 52. Middle East & Africa Propranolol Sales Market Share by Country (2018-2023)
    Table 53. Middle East & Africa Propranolol Revenue by Country (2018-2023) & ($ Millions)
    Table 54. Middle East & Africa Propranolol Revenue Market Share by Country (2018-2023)
    Table 55. Middle East & Africa Propranolol Sales by Type (2018-2023) & (K Units)
    Table 56. Middle East & Africa Propranolol Sales by Application (2018-2023) & (K Units)
    Table 57. Key Market Drivers & Growth Opportunities of Propranolol
    Table 58. Key Market Challenges & Risks of Propranolol
    Table 59. Key Industry Trends of Propranolol
    Table 60. Propranolol Raw Material
    Table 61. Key Suppliers of Raw Materials
    Table 62. Propranolol Distributors List
    Table 63. Propranolol Customer List
    Table 64. Global Propranolol Sales Forecast by Region (2024-2029) & (K Units)
    Table 65. Global Propranolol Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 66. Americas Propranolol Sales Forecast by Country (2024-2029) & (K Units)
    Table 67. Americas Propranolol Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 68. APAC Propranolol Sales Forecast by Region (2024-2029) & (K Units)
    Table 69. APAC Propranolol Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 70. Europe Propranolol Sales Forecast by Country (2024-2029) & (K Units)
    Table 71. Europe Propranolol Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 72. Middle East & Africa Propranolol Sales Forecast by Country (2024-2029) & (K Units)
    Table 73. Middle East & Africa Propranolol Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 74. Global Propranolol Sales Forecast by Type (2024-2029) & (K Units)
    Table 75. Global Propranolol Revenue Forecast by Type (2024-2029) & ($ Millions)
    Table 76. Global Propranolol Sales Forecast by Application (2024-2029) & (K Units)
    Table 77. Global Propranolol Revenue Forecast by Application (2024-2029) & ($ Millions)
    Table 78. Apotex Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 79. Apotex Propranolol Product Portfolios and Specifications
    Table 80. Apotex Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 81. Apotex Main Business
    Table 82. Apotex Latest Developments
    Table 83. Teva Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 84. Teva Propranolol Product Portfolios and Specifications
    Table 85. Teva Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 86. Teva Main Business
    Table 87. Teva Latest Developments
    Table 88. Atnas Pharma Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 89. Atnas Pharma Propranolol Product Portfolios and Specifications
    Table 90. Atnas Pharma Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 91. Atnas Pharma Main Business
    Table 92. Atnas Pharma Latest Developments
    Table 93. AstraZeneca Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 94. AstraZeneca Propranolol Product Portfolios and Specifications
    Table 95. AstraZeneca Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 96. AstraZeneca Main Business
    Table 97. AstraZeneca Latest Developments
    Table 98. Mylan Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 99. Mylan Propranolol Product Portfolios and Specifications
    Table 100. Mylan Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 101. Mylan Main Business
    Table 102. Mylan Latest Developments
    Table 103. Novartis Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 104. Novartis Propranolol Product Portfolios and Specifications
    Table 105. Novartis Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 106. Novartis Main Business
    Table 107. Novartis Latest Developments
    Table 108. Sanofi Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 109. Sanofi Propranolol Product Portfolios and Specifications
    Table 110. Sanofi Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 111. Sanofi Main Business
    Table 112. Sanofi Latest Developments
    Table 113. Yabang Pharma Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 114. Yabang Pharma Propranolol Product Portfolios and Specifications
    Table 115. Yabang Pharma Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 116. Yabang Pharma Main Business
    Table 117. Yabang Pharma Latest Developments
    Table 118. Sawai Seiyaku Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 119. Sawai Seiyaku Propranolol Product Portfolios and Specifications
    Table 120. Sawai Seiyaku Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 121. Sawai Seiyaku Main Business
    Table 122. Sawai Seiyaku Latest Developments
    Table 123. ABZ-Pharma Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 124. ABZ-Pharma Propranolol Product Portfolios and Specifications
    Table 125. ABZ-Pharma Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 126. ABZ-Pharma Main Business
    Table 127. ABZ-Pharma Latest Developments
    Table 128. Towa Yakuhin Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 129. Towa Yakuhin Propranolol Product Portfolios and Specifications
    Table 130. Towa Yakuhin Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 131. Towa Yakuhin Main Business
    Table 132. Towa Yakuhin Latest Developments
    Table 133. Zydus Pharma Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 134. Zydus Pharma Propranolol Product Portfolios and Specifications
    Table 135. Zydus Pharma Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 136. Zydus Pharma Main Business
    Table 137. Zydus Pharma Latest Developments
    Table 138. Nichi-Iko Pharmaceutical Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 139. Nichi-Iko Pharmaceutical Propranolol Product Portfolios and Specifications
    Table 140. Nichi-Iko Pharmaceutical Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 141. Nichi-Iko Pharmaceutical Main Business
    Table 142. Nichi-Iko Pharmaceutical Latest Developments
    Table 143. Intas Pharma Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 144. Intas Pharma Propranolol Product Portfolios and Specifications
    Table 145. Intas Pharma Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 146. Intas Pharma Main Business
    Table 147. Intas Pharma Latest Developments
    Table 148. IFET Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 149. IFET Propranolol Product Portfolios and Specifications
    Table 150. IFET Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 151. IFET Main Business
    Table 152. IFET Latest Developments
    Table 153. Iqfarma Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 154. Iqfarma Propranolol Product Portfolios and Specifications
    Table 155. Iqfarma Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 156. Iqfarma Main Business
    Table 157. Iqfarma Latest Developments
    Table 158. Zentiva Basic Information, Propranolol Manufacturing Base, Sales Area and Its Competitors
    Table 159. Zentiva Propranolol Product Portfolios and Specifications
    Table 160. Zentiva Propranolol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 161. Zentiva Main Business
    Table 162. Zentiva Latest Developments
List of Figures
    Figure 1. Picture of Propranolol
    Figure 2. Propranolol Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Propranolol Sales Growth Rate 2018-2029 (K Units)
    Figure 7. Global Propranolol Revenue Growth Rate 2018-2029 ($ Millions)
    Figure 8. Propranolol Sales by Region (2018, 2022 & 2029) & ($ Millions)
    Figure 9. Product Picture of Oral
    Figure 10. Product Picture of Injection
    Figure 11. Global Propranolol Sales Market Share by Type in 2022
    Figure 12. Global Propranolol Revenue Market Share by Type (2018-2023)
    Figure 13. Propranolol Consumed in Arrhythmia
    Figure 14. Global Propranolol Market: Arrhythmia (2018-2023) & (K Units)
    Figure 15. Propranolol Consumed in Hypertension
    Figure 16. Global Propranolol Market: Hypertension (2018-2023) & (K Units)
    Figure 17. Propranolol Consumed in Others
    Figure 18. Global Propranolol Market: Others (2018-2023) & (K Units)
    Figure 19. Global Propranolol Sales Market Share by Application (2022)
    Figure 20. Global Propranolol Revenue Market Share by Application in 2022
    Figure 21. Propranolol Sales Market by Company in 2022 (K Units)
    Figure 22. Global Propranolol Sales Market Share by Company in 2022
    Figure 23. Propranolol Revenue Market by Company in 2022 ($ Million)
    Figure 24. Global Propranolol Revenue Market Share by Company in 2022
    Figure 25. Global Propranolol Sales Market Share by Geographic Region (2018-2023)
    Figure 26. Global Propranolol Revenue Market Share by Geographic Region in 2022
    Figure 27. Americas Propranolol Sales 2018-2023 (K Units)
    Figure 28. Americas Propranolol Revenue 2018-2023 ($ Millions)
    Figure 29. APAC Propranolol Sales 2018-2023 (K Units)
    Figure 30. APAC Propranolol Revenue 2018-2023 ($ Millions)
    Figure 31. Europe Propranolol Sales 2018-2023 (K Units)
    Figure 32. Europe Propranolol Revenue 2018-2023 ($ Millions)
    Figure 33. Middle East & Africa Propranolol Sales 2018-2023 (K Units)
    Figure 34. Middle East & Africa Propranolol Revenue 2018-2023 ($ Millions)
    Figure 35. Americas Propranolol Sales Market Share by Country in 2022
    Figure 36. Americas Propranolol Revenue Market Share by Country in 2022
    Figure 37. Americas Propranolol Sales Market Share by Type (2018-2023)
    Figure 38. Americas Propranolol Sales Market Share by Application (2018-2023)
    Figure 39. United States Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 40. Canada Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 41. Mexico Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 42. Brazil Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 43. APAC Propranolol Sales Market Share by Region in 2022
    Figure 44. APAC Propranolol Revenue Market Share by Regions in 2022
    Figure 45. APAC Propranolol Sales Market Share by Type (2018-2023)
    Figure 46. APAC Propranolol Sales Market Share by Application (2018-2023)
    Figure 47. China Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 48. Japan Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 49. South Korea Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 50. Southeast Asia Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 51. India Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 52. Australia Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 53. China Taiwan Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 54. Europe Propranolol Sales Market Share by Country in 2022
    Figure 55. Europe Propranolol Revenue Market Share by Country in 2022
    Figure 56. Europe Propranolol Sales Market Share by Type (2018-2023)
    Figure 57. Europe Propranolol Sales Market Share by Application (2018-2023)
    Figure 58. Germany Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 59. France Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 60. UK Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 61. Italy Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 62. Russia Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 63. Middle East & Africa Propranolol Sales Market Share by Country in 2022
    Figure 64. Middle East & Africa Propranolol Revenue Market Share by Country in 2022
    Figure 65. Middle East & Africa Propranolol Sales Market Share by Type (2018-2023)
    Figure 66. Middle East & Africa Propranolol Sales Market Share by Application (2018-2023)
    Figure 67. Egypt Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 68. South Africa Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 69. Israel Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 70. Turkey Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 71. GCC Country Propranolol Revenue Growth 2018-2023 ($ Millions)
    Figure 72. Manufacturing Cost Structure Analysis of Propranolol in 2022
    Figure 73. Manufacturing Process Analysis of Propranolol
    Figure 74. Industry Chain Structure of Propranolol
    Figure 75. Channels of Distribution
    Figure 76. Global Propranolol Sales Market Forecast by Region (2024-2029)
    Figure 77. Global Propranolol Revenue Market Share Forecast by Region (2024-2029)
    Figure 78. Global Propranolol Sales Market Share Forecast by Type (2024-2029)
    Figure 79. Global Propranolol Revenue Market Share Forecast by Type (2024-2029)
    Figure 80. Global Propranolol Sales Market Share Forecast by Application (2024-2029)
    Figure 81. Global Propranolol Revenue Market Share Forecast by Application (2024-2029)

Apotex
Teva
Atnas Pharma
AstraZeneca
Mylan
Novartis
Sanofi
Yabang Pharma
Sawai Seiyaku
ABZ-Pharma
Towa Yakuhin
Zydus Pharma
Nichi-Iko Pharmaceutical
Intas Pharma
IFET
Iqfarma
Zentiva

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape